HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity ; volume:10 ; number:1 ; day:23 ; month:9 ; year:2013 ; pages:1-19 ; date:12.2013
Retrovirology ; 10, Heft 1 (23.9.2013), 1-19, 12.2013
- Creator
-
van den Kerkhof, Tom L G M.
- Contributor
-
Feenstra, K Anton
Euler, Zelda
van Gils, Marit J.
Rijsdijk, Linda W E.
Boeser-Nunnink, Brigitte D.
Heringa, Jaap
Schuitemaker, Hanneke
Sanders, Rogier W.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-10-102
- URN
-
urn:nbn:de:1111-2016080730126
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van den Kerkhof, Tom L G M.
- Feenstra, K Anton
- Euler, Zelda
- van Gils, Marit J.
- Rijsdijk, Linda W E.
- Boeser-Nunnink, Brigitte D.
- Heringa, Jaap
- Schuitemaker, Hanneke
- Sanders, Rogier W.
- SpringerLink (Online service)
Other Objects (12)
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
The Objective of Inducing Broadly Cross-reactive Neutralizing Antibodies Against HIV-1
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk